Ledger.Open graph →

SEC Form D · Amendment · filed April 14, 2017

Carmell Therapeutics Corp

Offering

$2.0M

Sold

$1.1M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

PITTSBURGH, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Richard Upton · Pittsburgh, PADirector David W. Anderson · Pittsburgh, PADirector Randolph Hubbell · Pittsburgh, PAExec · Director James F. Jordan · Pittsburgh, PADirector Donna Godward · Pittsburgh, PAExec James Hart · Pittsburgh, PAExec Stephanie W. Kladakis · Pittsburgh, PAExec Daniel P. Litteral · Phoenix, AZExec Ruth D. Veloria · Phoenix, AZExec · Director Peter J. Cohen · Phoenix, AZDirector Brooks A. Johnson · Boulder, COExec Sean P. Buckley · Phoenix, AZDirector Joan Blackwood · Phoenix, AZDirector Chris A. Lundquist · Boulder, CODirector Dennis T. Lawrence · Bozeman, MTExec Cory T. Lawrence · Bozeman, MTDirector Andrew El Bardissi · Carlsbad, CAExec · Director Yisroel Herzka · Lakewood, NJDirector David W. Sweaney · Ivine, CAExec Stephanie W. Kladakis · Pittsburgh, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗